SB 1754, titled the Preventing PLA Acquisition of United States Technology Act of 2025, is designed to limit U.S. research and commercial collaboration with Chinese entities that the bill identifies as tied to the Chinese Communist Party’s military-civil fusion strategy. It defines a broad category of “Chinese entity of concern,” including certain Chinese universities, state-owned or state-controlled enterprises, private companies with military production ties, and entities identified as Chinese military companies under existing federal lists.
The bill would prohibit covered U.S. entities — including federal research agencies, federally funded universities and research institutions, and U.S. private companies receiving federal financial assistance — from engaging in scientific research or technical exchanges with those entities when the work relates to specified dual-use or defense-relevant technologies. The bill directs the Department of Defense, in consultation with several other agencies, to maintain and update a public website listing the covered research areas and, to the extent practicable, the Chinese entities of concern. It also requires annual reporting by covered entities on existing, declined, or terminated research relationships, and authorizes audits of those reports.
The bill’s impact on state laws is indirect; it does not amend state statutes, but it would affect universities, research institutions, and companies operating in states by conditioning their access to federal financial assistance on compliance with the new restrictions. If enacted, it would create a federal compliance regime affecting research partnerships in fields such as quantum computing, semiconductors, biotechnology, artificial intelligence, aerospace, advanced nuclear technology, robotics, and telecommunications. It also gives the Secretary of Defense authority to issue regulations and coordinate enforcement across federal agencies.
The general sentiment reflected in the bill text is strongly national-security oriented and restrictive toward U.S.-China research ties in sensitive technology areas. Because there are no committee transcripts or votes provided, there is no recorded debate or vote history here to show broader legislative support or opposition. The bill’s structure suggests an intent to prevent technology transfer and reduce the risk of U.S.-origin research contributing to Chinese military modernization.
The main points of contention likely center on the breadth and enforceability of the restrictions. Potential concerns include how broadly “Chinese entity of concern” is defined, whether the covered technology list could sweep in legitimate academic collaboration, and how institutions would verify compliance with rapidly changing Chinese research and corporate structures. Another likely issue is the bill’s impact on universities and private research entities that rely on international collaboration, especially where the bill allows only a narrow exception for work determined not to substantially contribute to military-civil fusion goals.
The bill would establish a new federal prohibition on certain research collaborations and technical exchanges involving U.S. federally funded research entities and Chinese entities linked to military-civil fusion. It would not directly change state law, but it would effectively regulate state universities and other state-affiliated institutions that receive federal financial assistance by making compliance a condition of continued eligibility for federal funds. It also creates reporting, auditing, and enforcement duties for the Department of Defense and other federal agencies, with potential loss of federal financial assistance for covered private institutions and companies that violate the restrictions.
The bill’s tone and policy design are strongly hawkish and precautionary, reflecting concern that U.S. research and funding could aid Chinese military modernization. No committee transcript or vote data is provided, so there is no evidence here of bipartisan support, opposition arguments, or amendments. Based on the text alone, the bill appears to be framed as a national-security measure rather than a research-policy or trade measure.
Likely contention would focus on the scope of the definitions and the practical burden on universities, labs, and companies. Critics may argue that the bill could chill legitimate academic exchange, create compliance uncertainty, and require institutions to police foreign affiliations and research topics that are difficult to classify. Supporters would likely emphasize the need to block dual-use technology transfer and protect sensitive U.S. innovation from exploitation by entities tied to the People’s Liberation Army or other Chinese security organs.